Elotuzumab Approved for Multiple Myeloma
Mon, 30 Nov 2015 00:00:00 -0500
FDA today announced the approval of elotuzumab, in combination with lenalidomide and dexamethasone, for the treatment of multiple myeloma in patients who have previously received one to three therapies for the cancer.
Trivalent Flu Vaccine With Adjuvant Approved
FDA and Seqirus on November 25 announced the approval of Fluad, the first trivalent seasonal influenza virus vaccine that contains an adjuvant.
Necitumumab Approved for Metastatic Squamous Non-Small-Cell Lung Cancer
Tue, 24 Nov 2015 00:00:00 -0500
today announced the licensing of necitumumab, in combination
with gemcitabine and cisplatin, as first-line therapy for the treatment of metastatic
squamous non-small-cell lung cancer (NSCLC).
Palmetto Weathers South Carolina Flooding
The biggest threat to hospital operations during the historic rainstorm that struck the Columbia, South Carolina, area in October was the lack of water, said Dave Amsden, system director of pharmaceutical services and clinical nutrition for Palmetto Health Richland Memorial Hospital.
Advanced Pharmacy Services Support Multiple Myeloma Clinic
At the University
of Illinois Hospital and Health Sciences System Cancer Center in Chicago, a
care model that was put in place last March has clinical pharmacists working
closely with patients with multiple myeloma to help them manage their illness.